Novo Nordisk launched the high dose version of its GLP-1 injection at a price that’s $50 cheaper than Eli Lilly’s competing drug.
Novo Nordisk launched the high dose version of its GLP-1 injection at a price that’s $50 cheaper than Eli Lilly’s competing drug.